iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by M&T Bank Corp

M&T Bank Corp cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 53.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,910 shares of the financial services provider’s stock after selling 2,173 shares during the period. M&T Bank Corp’s holdings in iShares Biotechnology ETF were worth $244,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Bank of America Corp DE lifted its stake in iShares Biotechnology ETF by 6.5% during the fourth quarter. Bank of America Corp DE now owns 7,489,427 shares of the financial services provider’s stock valued at $990,177,000 after purchasing an additional 460,154 shares during the last quarter. Main Management ETF Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 3.2% in the fourth quarter. Main Management ETF Advisors LLC now owns 612,180 shares of the financial services provider’s stock worth $80,936,000 after buying an additional 18,810 shares during the period. Focus Partners Wealth boosted its holdings in shares of iShares Biotechnology ETF by 168.2% in the fourth quarter. Focus Partners Wealth now owns 121,996 shares of the financial services provider’s stock worth $16,485,000 after buying an additional 76,509 shares during the period. Madrona Financial Services LLC boosted its holdings in shares of iShares Biotechnology ETF by 153.0% in the first quarter. Madrona Financial Services LLC now owns 81,150 shares of the financial services provider’s stock worth $10,379,000 after buying an additional 49,075 shares during the period. Finally, Appleton Partners Inc. MA boosted its holdings in shares of iShares Biotechnology ETF by 3.4% in the first quarter. Appleton Partners Inc. MA now owns 78,382 shares of the financial services provider’s stock worth $10,025,000 after buying an additional 2,579 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 1.5%

Shares of IBB opened at $129.73 on Friday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $150.57. The company has a 50-day moving average of $126.09 and a two-hundred day moving average of $129.00.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.